DCF — HARLINGEN MEDICAL CENTER
Enterprise Value: $-28.3M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-28.3M
Enterprise Value
$-12.0M
PV of Cash Flows
$-16.3M
PV of Terminal Value
$-26.2M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $114.8M | $0.1M | 0.0% | $-4.8M | $-4.3M |
| Year 2 | $118.2M | $1.3M | 1.0% | $-3.7M | $-3.1M |
| Year 3 | $121.7M | $2.5M | 2.0% | $-2.6M | $-2.0M |
| Year 4 | $125.4M | $3.2M | 3.0% | $-2.1M | $-1.4M |
| Year 5 | $129.2M | $3.7M | 3.0% | $-1.9M | $-1.2M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-28.3M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$111.4M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.0042012768760291445
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5